Our pipeline encompasses the three major mechanistic areas: Immuno-Oncology, Targeted Therapies, and DNA Damage Response Inhibitors (DDRi).
EMD celebrates innovation in Fertility tools
Merck KGaA celebrates vibrant curiosity within its research and development divisions
EMD Serono takes on the MassBio D&I Pledge
MS Lifelines – Year of the Nurse – 2020
Women In Leadership Summit
EMD Serono – Multiplier Award Winners
Holiday Announcements – Thanksgiving announcement from the President Intro/Outro